drugset / Trial / NCT00638703
Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main purpose of this study is to determine if Oxalobacter formigenes is effective at lowering urinary oxalate levels in patients with primary hyperoxaluria.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-09
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxalobacter formigenes | Other / unclassified | 1e+07 unknown | — |